Primary record
Fludeoxyglucose Related Compound A, United States Pharmacopeia (USP) Reference Standard
- 库存
- 6,121 克
- 纯度
- 99.0 %
- CAS
- 23978-09-8
化合物标识与属性
- CAS
- 23978-09-8
- PubChem CID
- 72801
- SMILES
- C1COCCOCCN2CCOCCOCCN1CCOCCOCC2
- Canonical SMILES
- C1COCCN2CCOCCOCCN(CCO1)CCOCCOCC2
名称与同义词
- Kryptofix 222
- Cryptand 222
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
- 23978-09-8
- Cryptate 222
- Cryptating agent 222
- Cryptofix 222
- Kriptofix 222
- Kryptand 222
- Ligand 222
- Cryptand 2.2.2
- Cryptand C 222
- Cryptand-222
- 2,2,2-Cryptand
- Kryptofix-222
- 2,2,2-Crypt
- Crypt-2,2,2
- [2.2.2]cryptand
- Kryptofix Merck 222
- 2,2-Cryptand
- Cryptand[222]
- 2.2.2-Cryptand
- Crypt-222
- Cryptand[2.2.2]
- MFCD00005111
- C18H36N2O6
- RefChem:508187
- 18V22YHN6G
- UNII-18V22YHN6G
- ACMC-209g7j
- AC1L2IP5
- AC1Q70RH
- AUFVJZSDSXXFOI-UHFFFAOYSA-N
- SCHEMBL27017
- 2,2,2-CRYPTATE
- NSC 264495
- DTXSID00178697
- EINECS 245-962-4
- CRYPTAND 222 [MI]
- Fludeoxyglucose Related Compound A
- (2,2,2)CRYPAND
- orb1306550
- NSC-264495
- CTK1A2041
- KS-00000NVQ
- AMY5255
- BRN 0620282
- DTXCID60101188
- NSC264495
- Cryptand 222 (Kryptofix 222)
- CID72801
- ZINC3882229
- 1701AB
- ANW-25277
- BBL028994
- STK530369
- AKOS005463220
- AKOS015854436
- C18-H36-N2-O6
- ACN-028018
- CS-W011776
- DS-5217
- FC-4101
- HY-W011060
- RTR-011099
- N12CCOCCOCCN(CCOCCOCC1)CCOCCOCC2
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo(8.8.8)hexacosane
- AC-37613
- AJ-74266
- AK111408
- BB069210
- BC600194
- J49.432A
- K222
- LS-75514
- SC-48865
- SY010940
- 4-CYANO-2-METHYLPHENYLBORONIC ACID
- TR-011099
- A-(222)
- C-222
- FT-0617280
- H0932
- NS00020283
- ST50306906
- 13,16,21,24-Hexaoxa-1,10-diazabicyclo-(8,8,8)-hexacosane
- A51055
- 978H098
- A817018
- F239231
- FLUDEOXYGLUCOSE RELATED COMPOUND A [USP-RS]
- Q4596986
- I14-61495
- 4,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
- 13,14-Dioxatricyclo[8.2.1.14,7]tetradeca-4,6,10,12-tetraene
- 4,7,13,16,21,24-Hexa-oxa-1,10-diazabicyclo[8.8.8]hexacosane
- 4,7,13,16,21,24-hexaoxa-1,10-diaza-bicyclo[8.8.8]hexacosane
- 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo-[8.8.8]hexacosane
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98%
- 1,10-(Ethylenebisoxybisethylene)-1,10-diaza-4,7,13,16-tetraoxacyclooctadecane
- 1,10-[Ethylenebis[(oxy)(ethylene)]]-1,10-diaza-4,7,13,16-tetraoxacyclooctadecane
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]-hexacosane (Kryptofix 2.2.2)
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (Kryptofix(R) 222)
- 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98% - 1G 1g
- 7,16-(3,6-Dioxaoctane-1,8-diyl)(1,4,10,13-tetraoxa-7,16-diazacyclooctadecane)
- 7,16-(3,6-Dioxaoctane-1,8-diyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
- 7,16-(Ethylenebisoxybisethylene)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
- 7,16-(Ethyleneoxyethyleneoxyethylene)(1,4,10,13-tetraoxa-7,16-diazacyclooctadecane)
- 7,16-[Ethylenebis(oxyethylene)](1,4,10,13-tetraoxa-7,16-diazacyclooctadecane)
- 7,16-[Ethylenebis(oxyethylene)]-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
- Fludeoxyglucose Related Compound A, United States Pharmacopeia (USP) Reference Standard
- 245-962-4
- 5088-46-0